ArticleScientific reports2025
CEBPD regulates CD47 and MAP4K4 via chromatin accessibility in canine mammary tumor monocytes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the Role of the MAPK Signalling Pathway in Dog Immunity: From Cancer to Parasitic Diseases.Parasite immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Circulating immune cells that have interacted with tumor tissue exhibit distinct characteristics compared to those in healthy individuals, providing potential biomarkers for tumor presence and malignancy. However, the epigenetic mechanisms governing these immune cells, particularly chromatin accessibility, remain poorly understood in cancer. In this study, we investigated chromatin accessibility and transcription factor binding in peripheral blood mononuclear cells from dogs with mammary gland tumors using ATAC-seq. Our analysis revealed significant changes in chromatin accessibility near genes associated with immune function, neuronal activity, and lipid metabolism. Notably, we identified CEBPD-bound peaks that were upregulated in PBMCs from tumor-bearing dogs and demonstrated that the transcription of their associated genes, CD47 and MAP4K4, was also elevated in monocytes under cancer co-culture conditions. This effect was mitigated following CRISPR interference of these regulatory regions. These findings highlight the crucial role of chromatin accessibility in shaping the immune response to cancer and suggest potential therapeutic targets for immune modulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.